Sign up to save your podcasts
Or
Share AI Chats Episode 23: Why Should Pharma Invest in Patenting AI?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI Chats Episode 23: Why Should Pharma Invest in Patenting AI?
Welcome to a new episode of AI Chats, a podcast series produced by the law firm of Haynes and Boone, and lawyers from its AI and Deep Learning Practice Group to explore the exciting, ever-evolving, and occasionally controversial world of artificial intelligence.Today for our latest episode we are going to talk about Why Pharma Should Invest in Patenting AI. Moderator: Eugene Goryunov, Partner, Haynes and BooneFeatured Speakers: Vincent Shier, Partner, Haynes and BooneDina Blikshteyn...
View all episodes
By Haynes and Boone, LLPWelcome to a new episode of AI Chats, a podcast series produced by the law firm of Haynes and Boone, and lawyers from its AI and Deep Learning Practice Group to explore the exciting, ever-evolving, and occasionally controversial world of artificial intelligence.Today for our latest episode we are going to talk about Why Pharma Should Invest in Patenting AI. Moderator: Eugene Goryunov, Partner, Haynes and BooneFeatured Speakers: Vincent Shier, Partner, Haynes and BooneDina Blikshteyn...